It has previously been demonstrated that phenanthroline-based ligands used to make gold metallotherapuetics have the ability to exhibit cytotoxicity when not coordinated to the metal center. In an effort to help assess the mechanism by which these ligands may cause tumor cell death, iron binding and removal experiments have been considered. The close linkage between cell proliferation and intracellular iron concentrations suggest that iron deprivation strategies may be a mechanism involved in inhibiting tumor cell growth. With the creation of iron (III) phen complexes, the iron binding abilities of three polypyridal ligands [1,10-phenanthroline (phen), 2,9-dimethyl-1, 10-phenanthroline ( methyl phen), and 2,9-di-sec-butyl-1, 10-phenanthroline ( 
INTRODUCTION
Cancer is the 2nd leading cause of death in the United States. Though a wide variety of organic-based molecular compounds have been used to treat tumors, the metallotherapy cisplatin is one of the most successful anticancer drugs. Despite its success, cisplatin therapy has several drawbacks, including the development of resistance to the drug by tumors and the occurrence of severe side-effects during treatment [1] . It is well known that gold (III) complexes are potential alternatives to the platinum (II) based drugs [2] . Even though gold (III) complexes with polypyridyl based ligands [e.g., 1,10-phenanthroline (phen), 2,2'-bipyri-dine (bipy), and 2,2'-6',2''-terpyridine (terpy)] have shown promise as anticancer agents, it has also been shown that the polypyridyl ligands can have antitumor activity on their own; therefore the antiproliferative properties of the ligands must be considered when evaluating the antitumor activity of the corresponding metal-based complexes [1, 3, 4] .
We have previously reported the synthesis of a gold (III) complex bearing a 2,9-di-sec-butyl-1,10-phenanthroline ( sec-butyl phen)ligand {[( sec-butyl phen) AuCl 3 ]} [5] . The anti-tumor activity of this gold complex compound is currently being studied, therefore it is desired to determine the potential activity of the sec-butyl phen ligand. It has been previously hypothesized that chelating ligands can impact tumor cell death via iron depletion [6] . Additionally, Satterfield and Brodbelt reported that alkyl substituents on phenanthroline ligands have an impact on metal binding [7] , and this data predicts that sec-butyl phen should exhibit stronger metal binding than unsubstituted phen. To test whether alkyl substituted phenanthroline based ligands have different iron binding abilities, we synthesized and characterized iron complex ions with a series of phenanthroline-based ligands [phen, sec-butyl phen, and 2,9-dimethyl-1,10-phenanthroline ( methyl phen)], and evaluated the relative stability of these three complex ions.
MATERIALS AND METHODS

General Experimental Procedures
sec-butyl phen was synthesized according to a previously published protocol [8] ; phen and methyl phen were purchased from Sigma-Aldrich and used without purification, as were all other reagents and solvents used in the course of characterizing the iron (III) complex ions. UVVis spectra were recorded on a Varian Cary 50 UV-Vis spectrophotometer, and IR spectra were obtained using a Perkin Elmer Spectrum One FT-IR Spectrophotometer fitted with a Universal ATR sampling accessory. Mass spectrometric analyses were performed using a Waters GCT (2008) high resolution mass spectrometer, using Electrospray Ionization (ESI) and Liquid Injection Field Desorption Ionization (LIFDI) techniques.
Synthesis of [phenH][FeCl 4 ]·2H 2 O (1)
The iron (III) phen complex was synthesized using a previously published protocol [9] . A solution of 0.130 g FeCl 3 (0.802 mmole) in a 10 M aqueous HCl (10 mL) was added to a 150 mL reaction flask. To this was added 0.145 g (0.802 mmole) of 1,10-phenanthroline, which was dissolved in 10 mL of HCl. The ligand solution was added dropwise, upon which an orange color was observed. The solution was stirred overnight at room temperature, and an orange precipitate was formed. The solid was filtered and dried in vacuo, and 0.224 g of product was obtained after the solid was recrystallized from ethanol (77.3% yield). 
EDTA Competition Reaction
The EDTA binding reaction was modeled on a previously published protocol [10] . Stock solutions were prepared in 5 mL of acetonitrile using 10.0 mg of the phenanthroline iron complexes {2. M. A 0.028 M solution of EDTA in distilled water was prepared for the binding experiment. The EDTA solution was then added to the iron (III) complex ions in a 20:1 EDTA:iron molar ratio, and the UV-Vis absorption spectra were collected every minute for thirty minutes.
RESULTS AND DISCUSSION
Synthesis
The phen-iron complexes were synthesized by combining the phenanthroline ligand with FeCl 3 in a 1:1 molar ratio, in the presence of 10 M aqueous hydrochloric acid and water (Scheme 1). The resulting precipitates were then filtered, dried under vacuum, and recrystallized from ethanol to obtain the final complex ions. The products obtained were the complex ions comprised of the protonated phen ligand cation ( R phenH + ) and the FeCl 4 − anion. It is noted that previous work describing a similar synthetic protocol reported the formation of an iron (III) phen complex where the ligand was directly coordinated to the iron (III) metal center. However, the yield of this compound was extremely low, and was likely a minor side product in the reaction [9] . Khavasi and coworkers also report that the complex ion possessing [phenH] + and [FeCl 4 ] − was isolated after the reaction between phen and FeCl 3 in hot aqueous solution [11] . Other studies do demonstrate that complexes possessing direct coord-
+ FeCl3
HCl ( ination between phen and iron (III) can be isolated, however these are obtained by reacting equimolar amounts of phen with FeCl 3 in non-aqueous methanol [12] , or by refluxing the [phenH] [FeCl 4 ] complex ion in DMSO solvent [13] . 
Infrared Spectroscopy
IR results for compounds 1-3 show a single resonance at 3350 cm −1 , 3375 cm −1 , and 3200 cm −1 , respectively, indicating the presence of a protonated secondary amine and thereby providing additional evidence that the complex ions proposed in Scheme 1 were obtained. The presence of the R phen ligands is confirmed by the C−H aromatic resonances at 3051 cm −1 (1), 3051 cm −1 (2), and 3068 cm −
Mass Spectrometry
In addition to the elemental analysis and IR data, mass spectrometry indicates that [ + fragments, formed upon the loss of two chloride ligands, were indeed detected (see Figure 1 and Supplemental Data Figures 2 and 3) . It is also noted that compounds 2 and 3 exhibited fragment peaks in the LIFDI mode corresponding to the [ 
Ultraviolet Visible (UV-Vis) Spectroscopy
Compounds 1-3 were characterized by UV-Vis spec- troscopy. Although direct coordination of the ligand with the iron metal center was not achieved using the synthetic protocol described herein, the complex ions have absorption spectra that confirm the presence of both the protonated Figure 2) . The red shift in the π  π* charge transfer hasbeen previously reported as a result of the phen ligand coordinated to the metal iron, as have the presence of similar ligand-to-metal charge transfer bands in phenanthroline iron (III) chloride complexes [11] . The similarity between UV-Vis absorption spectra for complex ions possessing protonated phen ligands and coordination complexes possessing coordinated phen ligands has been noted before, specifically for [ 3(a) and (b) ). The decomposition of compounds 1 and 2 in the presence of EDTA was essentially instantaneous, as these spectral changes were observed within the first minute upon adding the EDTA solution.
Conversely, the sec-butyl substituted [ sec-butyl phenH] [FeCl 4 ] complex ion (compound 3) displayed behavior that was significantly different from the other two compounds in the series. Although the π  π* charge transfer band immediately shifts back to the absorbance maximum observed in the free ligand, there is a gradual decrease in the ligand-to-metal charge transfer bands at approximately 320 nm and 370 nm (see Figure 3(c) 4 ] complex ions, it appears that the sec-butyl phen ligand may provide some protection to iron (III) metal center. Satterfield and Brodbelt have previously quantified the ability of substituted phen ligands to bind metal cations, and their studies indicate that the larger sec-butyl substituent on the 2,9-positions of the phen ligand enhance metal binding [7] . Thus, the fact the sec-butyl phen ligand provides some protection of the iron (III) metal center is not completely unexpected. The LIFDI mass spectrometry data seem to provide fur- ).
